Harvard Bioscience Stock Forecast for 2023 - 2025 - 2030
Updated on 02/05/2023
Harvard Bioscience Stock Forecast and Price Target
Given the average yearlong price target of $10.00 provided by prominent analysts over the past few months, there is a potential upside of approximately 246.02% from the last closing price in January, 2023 for Harvard Bioscience's stock if it is reached. This estimation is based on a high estimate of $10.00 and a low estimate of $10.00. If you're interested in investing in this company, why not also look at its competitors to see how they are doing?
246.02% Upside
Harvard Bioscience Fair Value Forecast for 2023 - 2025 - 2030
Harvard Bioscience's Price has seen impressive growth In the last two years, rising from $3.94 to $5.47 – a growth of 38.89%. In the next year, 0 analysts estimate that Harvard Bioscience's Fair Value will decrease by 19.83%, reaching $4.39. According to professional forecasts, in 2030, Harvard Bioscience's Fair Value will decrease by 17.50%, reaching $4.51.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| TMO Stock Forecast | Thermo Fisher Scientific Inc | Outperform |
10
|
$587.76 | $618.99 | 5.49% |
| DHR Stock Forecast | Danaher Corp | Outperform |
10
|
$269.85 | $304.24 | 12.84% |
| BDX Stock Forecast | Becton, Dickinson and | Outperform |
17
|
$245.84 | $268.00 | 11.86% |
| LONN Stock Forecast | Lonza Group Ltd | Outperform |
16
|
CHF457.90 | CHF756.46 | 71.98% |
| PKI Stock Forecast | PerkinElmer | Outperform |
16
|
$138.56 | $159.83 | 17.28% |
Harvard Bioscience Revenue Forecast for 2023 - 2025 - 2030
Harvard Bioscience's Revenue has seen impressive growth In the last two years, rising from $116.18M to $118.90M – a growth of 2.34%. In the next year, 0 analysts estimate that Harvard Bioscience's Revenue will decrease by 4.82%, reaching $113.17M. According to professional forecasts, in 2030, Harvard Bioscience's Revenue will decrease by 4.75%, reaching $113.26M.
Harvard Bioscience Free Cash Flow Forecast for 2023 - 2025 - 2030
In the last two years, Harvard Bioscience's Free Cash Flow has decreased by 99.12%, going from $6.83M to $60.00k. Analysts predict that Harvard Bioscience's Free Cash Flow will increase in the upcoming year, reaching $5.47M. This would represent an increase of 9016.72%. Over the next nine years, experts predict that Harvard Bioscience's Free Cash Flow will grow at a rate of 705727503.16%.
Harvard Bioscience Net Income Forecast for 2023 - 2025 - 2030
In the last two years, Harvard Bioscience's Net Income has decreased from $-4.69M to $-290.00k – a 93.82% drop. In the next year, analysts predict that Net Income will jump to $-5.26M – up 1715.42% from the current level. Looking ahead to nine years, experts forecast that Net Income will grow by 280473.41%.
Harvard Bioscience EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Harvard Bioscience's EBITDA has decreased from $9.81M to $9.69M – a 1.22% drop. For the following year, the 0 analysts predict that Harvard Bioscience's EBITDA will drop by 4.34%, reaching $9.27M. In 2030, the professionals' prediction is that HBIO's EBITDA will decrease by 4.44%, reaching $9.26M.
Harvard Bioscience EBIT Forecast for 2023 - 2025 - 2030
Harvard Bioscience's EBIT has decreased by 0.00% In the last two years, from $2.07M to $2.07M. In the coming year, analysts are expecting an increase in EBIT, predicting it will reach $6.64M – an increase of 220.72%. Over the next nine years, experts anticipate that EBIT growth for Harvard Bioscience will be 652.51%.
Harvard Bioscience EPS Price Prediction Forecast for 2023 - 2025 - 2030
Harvard Bioscience's EPS has seen impressive growth In the last two years, rising from $0.18 to $0.25 – a growth of 38.89%. In the next year, 0 analysts estimate that Harvard Bioscience's EPS will decrease by 19.83%, reaching $0.20. According to professional forecasts, in 2030, Harvard Bioscience's EPS will decrease by 17.50%, reaching $0.21.